This would amount to between 400,000 and 500,000 unnecessary scans each month, the Verona, Wisconsin-based vendor said in recently published research.    

The agency's “B Reader Program” trains and certifies physicians to classify chest radiographs of workers participating in federal health surveillance programs. 

Gynesonics developed and sells the Sonata System, the first FDA-cleared product for diagnosis and treatment of certain symptomatic fibroids. 

Bethany Casagranda, DO, MBA, has served as chair of AHN’s Imaging Institute since 2017, growing the network’s radiologist roster from 28 to 124.  
 

New Year’s Day brought the go-live for California’s new law forbidding the use of AI to deny health insurance claims. 

Mercy Health-Lorain Hospital is suing the county after police revoked protection services for the Catholic facility, which refused to remove the baggie, citing safety concerns. 

Some FDA-approved medical devices age more safely than others. That’s no less true of AI-enabled technologies than of any others. The agency spells out the ramifications in draft guidance issued this week. 

The devices struggle to accurately read blood-oxygen levels in patients with darker and thicker skin. The FDA hopes that changes in design and improved clinical trials will improve clinical efficacy.

“POCUS in early pregnancy helps clinicians more efficiently and accurately diagnose problems without compromising the quality of needed first trimester assessments—saving time, money and stress for patients.” 

The National Mammography Quality Assurance Advisory Committee provides guidance and recommendations related to the standards by which facilities are regulated.